Related Experiment Videos

A high-throughput STAT binding assay using fluorescence polarization

P Wu1, M Brasseur, U Schindler

  • 1Tularik Inc., South San Francisco, California 94080, USA. wu@tularik.com

Insights

Researchers developed a new assay to find drugs that block STAT1 protein interactions with cell receptors, potentially modulating immune responses.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Immunology

Background:

  • Signal transducers and activators of transcription (STAT) are key transcription factors mediating immune responses.
  • STAT activation occurs downstream of cytokine and growth factor receptor signaling.
  • Modulating STAT-receptor interactions offers a potential therapeutic strategy for immune system regulation.

Purpose of the Study:

  • To develop a high-throughput biochemical assay for quantifying STAT1 and interferon-gamma receptor interactions.
  • To establish a screening platform for identifying small molecules that disrupt these critical protein-receptor interactions.

Main Methods:

  • Utilized fluorescence polarization to detect the binding between a phosphotyrosine-containing peptide derived from the interferon-gamma receptor and STAT1.
  • Developed a high-throughput assay suitable for large-scale screening.

Main Results:

  • Successfully established a biochemical assay to measure STAT1-receptor peptide interactions.
  • The assay demonstrated utility in detecting disruptions in this molecular interaction.

Conclusions:

  • The developed assay is a valuable tool for screening potential therapeutics targeting STAT-mediated immune pathways.
  • This method can identify small molecules capable of inhibiting receptor-STAT interactions, offering a novel approach to immune response modulation.

Related Concept Videos